A B S T R A C T To determine the role of thyrotropinreleasing hormone (TRH) in the regulation of thyroidstimulating hormone (TSH) secretion in the perinatal period, a physiological approach of neutralizing circulating TRH in the fetal andl early neonatal rat was employed. TRH-antiserum (TRH-AS) raised in rabbits and administered daily to low iodine-propylthiouracil (LID-PTU)-fed pregnant rats from days 12 to 19 of gestation markedly impaired the rise in serum TSH to LID-PTU when compared with normal rabbit serumtreated controls. In contrast, fetal serum TSH was unaffected by TRH-AS. The binding capacity of TRH-AS in the fetal serum (111 ng/iiil) far exceeded circulating TRH in the fetus. Similarly7, acute TRH-AS administration to the pregnant rat fed LID-PTU markedly decreased the serum TSH concentration in the mother, but not in the fetus, 60 niin after TRH-AS administration. Chronic TRH-AS administration to neonatal rats whose nursing mothers were fed LID-PTU was ineffective in decreasing the elevated serum TSH in the neonate through day 8 of life, whereas a slight but significant decrease in serum TSH was observed on day 10. Chronic daily TRH-AS administration to neonatal rats through day 10 of life had no effect on the later development of the hypothalamic-pituitary-thyroid axis. These findings suggest that TRH does not participate in TSH regulation during the perinatal life in the rat and that thyroid hormones are probably the main regulators of TSH secretion during this period.
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Placental TRH is niot importanit in regulating TSH secretion in the fetal rat. Furthermore, TRtH "deprivation" during neonatal life does not prevent normal later developmenit of the hypothalamic-pituitarythyroid axis.
INTRODUCTION
In animals and man, thyroid-stimulating hormone (TSH)' secretion is stimulated by the hypothalamic thy'rotropin-releasing hormoine (TRH), and the TSH response to TRH is modulated by the thyroid hormones, thyroxine and triiodothyronine. Evidence for the TRH control of TSH seiLretion has been derived mainly from animal studies with hypothalamic lesions, basal hypothalamic deaffereintation, or heterotopic pituitary transplantation, all of which result in a decrease in pituitary TSH secretion (1) (2) (3) (4) (5) . Recently, we and others (6) (7) (8) have reported that passive immunization with TRH' antibody results in a marked decrease in the basal and cold-stimulated TSH secretion in the normal and hypothyroid adult riat, although the role of endogenous TRH in maintaining increased serum TSH in the hypothyroid rat has been questioned (9) .
In the fetus, previous studies have suggested that the hypothalamus and brain are inot involved in the regulation of TSH secretion because enceephalectomized fetuses with intact pituitaries developed goiters as large as normal controls when pregnant rats were fed antithyroid drugs (10) (11) (12) . More recently, Tonooka and Greer (13) reported that serum TSH in encephalectomized fetuses was markedly elevated when pregnant rats were fed propylthiouracil (PTU) and that hypothalamic lesions in these PTU-fed pregnant rats did not prevent the TSH rise in the fetuses. Although these studies suggest that fetal and maternal TRH do not regulate TSH secretion in the fetus, this surgically treated model may not be optimal to study the physiological role of TRH. Encephalectomy also eliminates the possible effects of other brain neutrotransmitters ' Abbreviations used in this paper: LID-PTU, low-iodinepropylthiouracil; NRS, n-ormal rabbit serum; PTU, propylthiouracil; RIA, radioimmunoassay; T3, triiodothyronine; T4, thyroxine; TRH, thyrotropin-releasing hormone; TRH-AS, TRH antiserum; TSH, thyroid-stimulating hormone.
on TSH synthesis and release. The recent observation that the rat placenta contains considerable quantities ofTRH (14}which probably reaches the fetus and could serve as an extracerebral source of TRH in the encephalectomized fetus raises the possibility that TRH may still be important in TSH regulation in the fetal rat. The present studies, therefore, were carried out under more physiological conditions by administering TRH antiserum (TRH-AS) to the pregnant rat to neutralize circulating TRH in the fetus and thus explore the role of TRH in regulating fetal TSH secretion. The effect of TRH-AS on serum TSH concentration in the hypothyroid neonatal rat was also studied.
METHODS
Acute and chronic administration of TRH-AS to pregnant rats. Female Sprague-Dawley rats weighing 200-250 g were used in all experiments. The day of conception was accurately assessed by obtaining vaginal smears for identification of spermatozoa. To determine whether TRH-AS crosses the placenta, 0.4 ml i.p. TRH-AS was injected to four pregnant rats on day 21 of gestation, and blood obtained 60 min later from the mothers and fetuses and the presence of TRH-AS in the serum determined. Other rats were fed low iodine (0.03 ,g/g)-propylthiouracil (0.15%) diet (LID-PTU) from days 12 to 19 of pregnancy. These rats were injected with 0.3 ml i.p. TRH-AS daily from days 12 to 19 of gestation. Control rats were injected with 0.3 ml normal rabbit serum (NRS). The TRH-AS employed in these experiments displayed a binding capacity of 48 nM/liter and when used in the TRH radioimmunoassay in a dilution of 1:50,000, 30% of [1251]TRH was bound to antiserum (6) . Blood was obtained by heart puncture from the pregnant rats under light ketamine anaesthesia, the fetuses were removed through cesarian section, and fetal blood was collected from the trunk, after decapitation. In another experiment, the rats were maintained on LID-PTU diet from day 14 to 21 of gestation, and 0.3 ml of TRH-AS or NRS was injected daily until day 20 of gestation. Blood was obtained on days 14, 17 , and 21 of gestation, 24 h after TRH-AS or NRS administration. Maternal blood and pooled blood from fetal siblings were centrifuged, and serum obtained and quickly frozen until assayed for TSH. The presence and binding characteristics of the TRH-AS in fetal serum were determined by Scatchard plot analysis (15) . Fetal thyroids, pituitaries, hypothalami, and extra hypothalamic brain tissues were separately pooled, whereas matern4l tissues were individually studied. The thyroids were weighed. The pituitaries were frozen on dry ice, weighed, and homogenized in 4 ml 0.01 M P04 buffer (pH 7.5) and stored at -20°C until assayed for TSH content. The hypothalami and brains were quickly frozen on dry ice, weighed, and homogenized in 1 and 4 ml 90% methanol, respectively. The methanol extracts were evaporated under nitrogen, kept frozen, and reconstituted in 2 ml 0.01 M P04 buffer just before determining TRH content.
The effect of a single dose of TRH-AS on maternal and fetal serum TSH concentrations 'was evaluated as follows.
Pregnant rats fed the LID-PTU diet from days 18 to 21 of gestation were injected with single dose of0.4 ml i.v. TRH-AS or NRS. Six TRH-AS-treated rats and seven NRS-treated control rats were studied. Blood was obtained from the dams 30 min after intravenous injection.-The dams were then sacrificed 30 min later, and maternal and fetal blood obtained. Sera from fetuses obtained from the same dam were pooled.
Acute and chronic TRH-AS administration to neonatal rats. 10-d-old neonatal rats, whose mothers were fed LID-PTU after delivery, received a single injection of 0.1 ml i.p. TRH-AS or NRS and were sacrificed 30, 60, and 120 min later. An adequate quantity of serum could be obtained from each 10-d-old neonate. The lactating mothers were injected with 0.4 ml i.p. TRH-AS, and serum was obtained 30, 60, and 120 min thereafter to determine the efficacy of the antiserum in neutralizing circulating TRH in the hypothyroid, adult rat.
Neonatal rats, 5 d old, whose mothers were fed LID-PTU diet after delivery were injected with 0.1 ml i.p. TRH-AS or NRS daily for 5 d. The neonatal rats were sacrificed by decapitation at 5, 8, and 10 d of age, 24 h after the last injection, and blood was collected. Serum was frozen until assayed for TSH. The TRH binding capacity in sera from rats treated with TRH-AS was also assessed.
To determine whether the presence of TRH during neonatal life is important for the later development of the hypothalamic-pituitary-thyroid axis, neonatal rats fed Purina chow (Ralston Purina Co., St. Louis, Mo.) were injected with 0.1 ml i.p. TRH-AS or NRS on days 1, 2, 3, 4, 6, 8, and 10 of age. They were then studied at age 40 d. Basal serum thyroxine (T4), triiodothyronine (T3), and TSH concentrations, the thyroid 131I-uptake, the serum TSH response to TRH, and the serum TSH response to a LID-PTU diet were assessed.
Measurement of immunoreactive TRH in fetal serum. 10 separate pools of blood obtained from 21-d-old fetuses from normal pregnant rats were extracted immediately with 90% methanol. The extraction efficiency was calculated from the recovery of ['25I]TRH added to the blood. The volume ofblood in each pool was estimated by the addition of the blood to known volumes of methanol in graded centrifuge tubes. The methanol extract was dried under nitrogen and reconstituted with 0.1 ml of 0.01 M P04 buffer, pH 7.5. Five of the extracted pools were incubated with 0.2 'ml fresh normal adult rat serum at 37°C for 1 h which deactivates immunoreactive TRH. The other five pools were also incubated with 0.2 ml adult rat serum whose TRH deactivating activity was destroyed by preheating the serum at 56°C for 2 h. The TRH content in 50 /.Ll of the incubate was then measured by radioimmunoassav (RIA). The standards were incubated with 50 ,ul of preheated rat serum to e(qualize the quantity of protein in the unknown samples.
Hormone measurements. Serum TSH was measured by RIA with material kindly distributed by the National Pituitary Agency, National Institute of Arthritis, Metabolism, and Digestive Diseases (Dr. A. Parlow). Hypothalamic and serum TRH was assayed by RIA by the method of Bassiri and Utiger (16) (17) (18) as modified in our laboratory (19) . Serum T3 and T4 concentrations were measured by RIA. Statistical analysis was carried out by the Student's t test and, when indicated, by the paired t test.
RESULTS
Evidence that TRH-AS crosses the placenta. TRH-AS administered intravenously or intraperitoneally to the pregnant rat crosses the placenta. Fetal serum obtained 60 min after the administration of0.4 ml TRH-AS to pregnant rats bound '251-labeled TRH added in vitro.
10 gl fetal serum bound 44±+4% (mean±SE), whereas 10 ,ul maternal serum bound 60+10% of 1251-TRH (final dilution, 1:500 observed in the NRS-treated control dams (Fig. 1) . In contrast, fetal serum TSH remained elevated after daily injections of TRH-AS for 7 d to the pregnant rat and was almost identical to that obtained in fetuses from control rats (n = 7) treated with NRS (TRH-AS 86+±24 vs. NRS 88±16 ,uU/ml). 24 h after the last injection of TRH-AS to the dams, the affinity constant (K) ofthe pooled fetal serum was 1.78 x 10-9 liters/mol and the binding capacity (C) was 0.41 nM/liter, clearly exceeding the circulating serum, hypothalamic, and brain TRH content. Pituitary TSH content was increase(l in LID-PTU-fed dams treated with TRH-AS (TRH-AS 80±12 vs. NRS 21±3.9 mU/mg pituitary, P < 0.001). In contrast, fetal pituitary TSH was not significantly affected by the administration of TRH-AS to the pregnant rat (TRH-AS 50±10 vs. NRS 35±6 ,uU/ pituitary). Similar results were obtained in another experiment. The serum TSH in NRS-treated pregnant rats (n = 6) was increased from basal values of 13.2 +1.5 to 217±50 ,uU/ml 3 d after the institution of the LID-PTU diet (day 17) and remained elevated (160+26 ,U/ml) on day 21. In contrast, in the TRH-AS-treated group (n = 4), serum TSH was 68±8 (day 17) anid 93± 10 ,uU/ml (day 21), significantly different friom the control NRS-treated rats (P < 0.02 and < 0.05, respectively). Fetal serumii TSH was not significantly different (TRH-AS 256±7 vs. NRS 165±24 ,UIml). The brain and hypothalamic TRH content was not affected by the TRH-AS in either the dam or the fetus. Similarly, thyroid weights in the dams and fetuses were identical in both groups (Table I) .
Serum T4 in the dams was barely detectable 7 d after the institution of LID-PTU diet, whereas T3 was low in both groups (TRH-AS 25±1 vs. NRS 22±3 ng/dl). Serum T4 and T3 in the fetuses were undetectable in all groups.
Effect of acute TRH-AS administration to the LID-PTU-fed pregnant rat on maternal andfetal TSH. We have previously reported (6) that in the hypothyroid rat, acute TRH-AS administration resulted in a decreased serum TSH concentration 30, 60, and 120 min later, but that this effect was no longer seen after 120 Fetal serum TSH concentration was not signiificantly affected by TRH-AS (TRH-AS 148+27 vs. NRS 182 +24 ,uU/ml), whereas maternal serum TSH concentration was significantly decreased at 30 min (TRH-AS 26+6 vs. NRS 100+21 ,uU/ml, P < 0.01) and 60 min (TRH-AS 35± 11 vs. 100±24,U/ml, P < 0.025) (Fig. 2) . The calculated in vitro binding capacity of fetal serum varied from 35 to 50 ng TRH/ml, verifying the presence of a high concentration of TRH-AS.
Effect of acute TRH-AS adminiistr(ation on nteontatal and maternal serum TSH in LID-PTU-fed lactatitng rats. Serum TSH concentration in neonatal rats whose mothers were fed LID-PTU since delivery was elevated as observed in primlary hypothyroidism. The increased serum TSH concenitrationi was not affected by the administration of TRH-AS (Fig. 3) . The presence of TRH-AS in the neonatal rat sertum was verified as described previously. The calculated TRH binding capacity of the neonatal serumiii in the TRH-AS-treated group varied from 80 to 100 ng TRH/ml.
In contrast to the findings in the neonatal rat, when lactating mothers were injected with 0.3 ml i.p. TRH-AS, a marked decrease in serumii TSH concenitration occurred at 30, 60, and 120 min later (P < 0.001) when compared with NRS-treated controls (Fig. 4) (Table II) . Similarly, when these rats were challengedl with LID-PTU diet, no difference in the increase in serum TSH was observed between the previously treated TRH-AS and NRS groups. Basal serum T4 and T3 concentrations and the 3-h thyroid radioactive iodine uptake were also similar in the TRH-AS-treated and NRS-treated rats (Table II) 
DISCUSSION
The present study clearly demonstrates that the circulating immunoreactive TRH in the fetal and early neonatal rat is not involved in the regulation of TSH secretion. Although similar conclusions were made from earlier studies with fetal encephalectomy and maternal hypothalamic lesions (10-13), the present report differs from these studies in many respects. First, all previous studies involving fetal encephalectomy and maintenance of an isolated pituitary island cannot be considered physiological because extensive surgical manipulation is involved. Second, possible remnant neural connections between residual hypothalamic tissue and the pituitary gland after encephalectomy or hypothalamic lesions cannot be excluded. Third, a possible role of placental TRH in rat (14) and man (20) in regulating fetal TSH synthesis and release could not be excluded in these studies. It is possible that the failure to observe a decrease in serum TSH in the fetus after encephalectomy, with or without hypothalamic lesions in the mother, may be due to the passage of placental TRH into the fetal circulation which could stimulate the fetal pituitary gland. Although there is no definitive evidence that placental tissue releases TRH into the fetal circulation, our studies suggest that whether or not this occurs, circulating TRH in the fetus, whatever its source, is not involved in fetal TSH secretion under physiological conditions. This conclusion is further strengthened by the finding that the pituitary thyrotroph is not dependent upon TRH during early neonatal life, because TRH-AS administration did not decrease serum TSH concentration in the hypothyroid neonatal rat but was effective in decreasing serum TSH concentration in their LID-PTU-fed lactating mothers. The slight but significant decrease in serum TSH concentration in the 10-d-old neonatal rats whose mothers were fed a LID-PTU diet suggests that the neonatal pituitary is responsive to endogenous TRH by 10 d of age and indicates the initiation of the dependence of TSH regulation upon TRH secretion. Several possibilities are raised, however, in an attempt to explain the failure of TRH-AS to decrease serum TSH in the fetal and early neonatal rat. First, it may be argued that the quantity of TRH-AS administered to the pregnant rat which reached the fetus was inadequate to neutralize circulating TRH in the fetus or that its binding efficiency was lost because of degradation during its passage through the placenta. However, this is most unlikely because fetal serum from mothers injected with TRH-AS was found to bind (24) . However, capillaries with the characteristics of primary portal vessels are present along the ventral surface of the median eminence very early in fetal life (24) . The finding that corticotrophini and growth hormoine secretion are markedlv impaired after hypothalacmic lesions in rat fetuses (25) (26) (27) , whereas TSH secretion is unaffected, suggests that TRH, corticotrophin-releasing factor, and growth horimone-releasiing factor are trainsported to the pituitary through the mediani eminience aniid that TRH does not regulate TSH secretion. This imiayI be due to a decreatse in the niumnlber of TRH receptor sites in the pituitary thyrotroph during perinatal life although direct experimental evidence is lacking. The present findings and those of Tonooka and Greer (13) suggest that the perinatal pituitary thyrotroph is exquisitely sensitive to the inhibitory effects of thyroid hormones. This may explain, at least in part, the low serum TSH in the perinatal rat in the presence of very low concentrations of thyroid hormones and the increased serum TSH response after thyroid hormone deprivation. This is reminiscent of the increased sensitivity of the hypothalaiic-pituitary axis to the inhibitory effects of the gonadal steroids during prepubertal life in man and the increased sensitivity of the pituitary thyrotroph to the inhibitory effect of thyroid hormonies in adult rats with hypothalamic lesionis (5) . Thus, in the perinatal rat, TSH secretion is primarily regulated by the thyroid hormones acting unlopposed on a pituitary with a low set point. The higher threshold of TSH secretioni is (levelope(l later in life under the influenice of TRH.
The biological inactivationi of TRH during early neonatal life does not appear to influence the later developmient of a normiial hypothalamic-pituitarythyroid axis because prolongedI admiiniistration of TRH-AS, and presumnably neutralizationi of circulatinig TRH during neoniatal life, had no effect on basal anid stimiiulated TSH secretion in adult life. This is in conitrast to the essential role of luteinizing hormonie-releasing hormonie during the neonatal period which appears to be important for the normiial developmiient of gonadal function in the adult rat (28) . \We have previously reported that TRH is anl important modulator of TSH secretioni in the normiial anid hypothyroid adult rat (6) . The present studies conifirmii and(l extenid these previous ol)servations and suggest that TRH contributes substantiallv to the increasedl TSH secretioni in hypothyroidismii. The rapidity of the reductioni of serumii TSH anid the sustainied effect of TRH-AS oni lowerinig serumii TSH concenltrationi in the hypothyroid, pregnant and lactating rat observed in the presenit study suggest thatt TRH secretioni is re(quire(d to mainitaini the marked inierease in seirumll TSH conicenitration in adult hypothyroidism.
